Next-generation Sequencing Identifies CDKN2A Alterations As Prognostic Biomarkers in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Predominantly Receiving Immune Checkpoint Inhibitors
FRONTIERS IN ONCOLOGY(2023)
Key words
next-generation sequencing,head and neck squamous cell carcinoma,cyclin-dependent kinase inhibitor 2A,prognosis,immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined